Researchers have found that NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance. The discovery may have implications for cancer, with some studies suggesting that lactylation plays a role in cell death resistance and therapeutic vulnerability. However, the connection to cancer is not clear, as reports also mention unrelated topics, such as dementia and dinosaur fossils, in the context of cancer research.